Skip to content

Drug interactions

Eslicarbazepine + Osimertinib

Severity: Major

Eslicarbazepine and Osimertinib: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Eslicarbazepine may lower osimertinib exposure via CYP3A4 induction. Reduced exposure may compromise tumor control.

What this interaction means in plain words

Eslicarbazepine and Osimertinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Eslicarbazepine belongs to Central Nervous System; Osimertinib belongs to Oncology.

Evidence level: Moderate

Why it happens

CYP3A4 induction increases osimertinib clearance.

What to do

Avoid combination; use a non-inducing anticonvulsant, and monitor tumor response if unavoidable.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Eslicarbazepine and Osimertinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Eslicarbazepine with Osimertinib?

MediHelp rates the interaction as major. Eslicarbazepine and Osimertinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Eslicarbazepine may lower osimertinib exposure via CYP3A4 induction. Reduced exposure may compromise tumor control.

How serious is the interaction between Eslicarbazepine and Osimertinib?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid combination; use a non-inducing anticonvulsant, and monitor tumor response if unavoidable.

What other medicines interact with Eslicarbazepine?

MediHelp also lists interactions of Eslicarbazepine with, for example, Mavacamten, Rilpivirine, Artemether / lumefantrine. The full list is on the Eslicarbazepine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in